Nebilet Hctz (Hydrochlorothiazide, Nebivolol)

Nebivolol and Hydrochlorothiazide, the active ingredient in Nebilet Hctz, is a beta‑blocker; thiazide diuretic presented as an oral tablet for systemic use. It is indicated for the management of hypertension in adult patients.

GNH USA supplies Nebilet Hctz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from competitive pricing, regulatory support, and timely delivery across multiple continents.

Nebilet Hctz is used to lower elevated blood pressure, a key component of cardiovascular risk management.

Hypertension: Reduces systolic and diastolic blood pressure, helping patients achieve guideline‑recommended targets. Essential hypertension: Controls persistent high blood pressure when lifestyle measures are insufficient. Secondary hypertension: Assists in blood pressure control associated with renal or endocrine disorders.

Nebilet Hctz may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Increased urination

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Acute kidney injury - Bradycardia or symptomatic heart block

When prescribing Nebilet Hctz, several safety considerations should be observed.

Monitor blood pressure: Check regularly to ensure therapeutic response and avoid hypotension. Assess renal function: Periodic evaluation of serum creatinine and electrolytes is recommended. Evaluate electrolyte status: Watch for potassium and sodium disturbances, especially with concomitant diuretics. Caution in diabetes: May mask hypoglycaemia symptoms; adjust glucose monitoring. Avoid abrupt discontinuation: Tapering is advised to prevent rebound hypertension. Store at ambient temperature: Keep below 25 °C, in the original container, protected from moisture and light.

Nebilet Hctz can interact with several drug classes; awareness helps maintain efficacy and safety.

Major Interactions (Avoid): - Concomitant use with other β‑blockers: May cause excessive bradycardia and hypotension. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): Can increase nebivolol plasma levels. - Lithium: Thiazide component can raise lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen, naproxen): May reduce antihypertensive effect of hydrochlorothiazide. - ACE inhibitors or ARBs: Combined use can enhance renal effects; monitor kidney function. - Antidiabetic agents: Diuretic‑induced changes in glucose may require dose adjustment.